Literature DB >> 26761372

Resolution of Extensive Coronary Thrombosis under Rivaroxaban Treatment.

Murat Yuksel1, Abdulkadir Yildiz1, Umit Tapan2, Faruk Ertas1, Sait Alan1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26761372      PMCID： PMC4693669          DOI： 10.5935/abc.20150052

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN： 0066-782X            Impact factor:   2.000


× No keyword cloud information.
  4 in total

1.  PAI-1 promoter 4G/5G genotype as an additional risk factor for venous thrombosis in subjects with genetic thrombophilic defects.

Authors:  R Seguí; A Estellés; Y Mira; F España; P Villa; C Falcó; A Vayá; S Grancha; F Ferrando; J Aznar
Journal:  Br J Haematol       Date:  2000-10       Impact factor: 6.998

2.  A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis.

Authors:  S R Poort; F R Rosendaal; P H Reitsma; R M Bertina
Journal:  Blood       Date:  1996-11-15       Impact factor: 22.113

3.  Association of protein S deficiency with thrombosis in a kindred with increased levels of plasminogen activator inhibitor-1.

Authors:  C D Bolan; C Krishnamurti; D B Tang; L R Carrington; B M Alving
Journal:  Ann Intern Med       Date:  1993-10-15       Impact factor: 25.391

4.  Association between plasminogen activator inhibitor 1 gene mutation and different subgroups of recurrent miscarriage and implantation failure.

Authors:  Farhad Khosravi; Saeed Zarei; Negah Ahmadvand; Zahra Akbarzadeh-Pasha; Elham Savadi; Amir-Hassan Zarnani; Mohammad-Reza Sadeghi; Mahmood Jeddi-Tehrani
Journal:  J Assist Reprod Genet       Date:  2013-11-06       Impact factor: 3.412
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.